|

exosomes treatment group Clinical Trials

1 actively recruiting trial

Also known as: GoldenExo（NATX） treatment group

Pipeline

Phase 1/2: 1

Top Sponsors

  • Peking University First Hospital1

Indications

  • Type 2 Diabetes Mellitus (T2DM)1
  • Diabetes1

Other1 trial

hUC-MSC-Exosomes for T2DM - Safety & Efficacy
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.